Recently, the intelligent orthopedic team led by Jiang Xieyuan, President of Beijing Jishuitan Hospital, and Wang Junqiang, Director of the Intelligent Orthopedic Research Ward, successfully treated a 90-year-old patient with pelvic fracture using the Tianji orthopedic surgical robot assisted percutaneous pelvic passage screw placement technology.
Percutaneous pelvic access screw placement is a difficult and high-risk procedure. However, under the guidance of the millimeter-level precision of the Tianji orthopedic surgical robot, the operation took a total of one and a half hours, the intraoperative bleeding was less than 20 ml, and the length of the incision at the place where each screw was inserted was about 1.5 cm, which met the surgical expectations.
TiRobot is the result of Beijing TINAVI Medical Technology Co., Ltd. (hereinafter referred to as "TINAVI") in the field of orthopedic surgical robots for many years.
According to a set of data released by TINAVI recently, up to now, the clinical application of the Dimensity series of orthopedic surgical robots has covered more than 200 medical institutions, and the total number of surgeries completed has exceeded 100,000. In an interview with Science and Technology Daily, Ma Min, President and Director of TINAVI, said: "The Dimensity orthopedic surgical robot has gradually realized the closed loop of clinical application. "
Ma Min introduced that the innovative Tianji orthopedic surgical robot has achieved "one machine with multiple indications" coverage, including cervical spine, thoracic spine, lumbar spine, sacral spine full-segment spine surgery, pelvic, acetabulum, limb and other parts of the trauma surgery, as well as hip and knee replacement surgery. This is the world's first "trinity" universal orthopedic surgical robot. According to statistics, in 2024, the annual average number of surgical robots of Tianji orthopedic surgical robots has exceeded 150 cases per unit, and the average annual number of surgical robots is gradually approaching the international standard of 200 surgical robots.
"The number of surgeries will continue to climb." When talking about the core advantages of Tianji orthopedic surgical robots, Ma Min said, first, adhere to the completely independent and original technical route and master the core technology; Second, it has high reliability and safety, rich clinical application cases, and strong comprehensive product strength.
With the continuous development and application of a new generation of information technologies such as artificial intelligence, big data, and cloud computing, the medical technology industry will be more intelligent, personalized and precise.
Ma Min said that in the future, TINAVI will continue to carry forward the spirit of perseverance in original research, integrate innovation into every aspect of product design, R&D and manufacturing, and promote the wide application and in-depth development of artificial intelligence and other technologies in the medical field. Although the prospect is bright, Ma Min also said frankly that domestic surgical robot companies have not yet had a profit record, "although the clinical application has completed the closed loop, but the closed loop of business logic is still in the process of exploration and improvement."
"The whole industry expects the relevant government departments to give more policy support to surgical robots in medical insurance, fees, commercial insurance and other links, just like supporting new drugs and special drugs." Ma Min said, "Only by opening up the closed loop of business logic can domestic surgical robot companies be stable and far-reaching." "